The enzymatic degradation phase accounted for the biggest earnings share in 2023. The segment’s advancement is attributed to its desire over option strategies for primary cell separation as a consequence of Gains for instance lessened damage to cultures and comparatively fast and significant produce of the representative sample. What's more, enzy